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Eukaryotic transcriptional activators are minimally comprised of a
DNA binding domain and a separable activation domain; most
activator proteins also bear a dimerization module. We have
replaced these protein modules with synthetic counterparts to
create artificial transcription factors. One of these, at 4.2 kDa,
mediates high levels of DNA site-specific transcriptional activation
in vitro. This molecule contains a sequence-specific DNA binding
polyamide in place of the typical DNA binding region and a
nonprotein linker in place of the usual dimerization peptide. Thus
our activating region, a designed peptide, functions outside of the
archetypal protein context, as long as it is tethered to DNA.
Because synthetic polyamides can, in principle, be designed to
recognize any specific sequence, these results represent a key step
toward the design of small molecules that can up-regulate any
specified gene.
According to our current picture, an activator binds to itscognate sites in the genome and recruits the transcrip-
tional machinery to nearby promoters; initiation of transcrip-
tion then follows (1). The yeast activator Gal4, like many
eukaryotic activators, comprises three separable modules:
DNA binding, dimerization, and activation (1–3). Each of
these modules can be ‘‘swapped’’ with corresponding modules
from other activator proteins (1, 2, 4, 5). Additional regulatory
nuances have in some cases been superimposed on these three
essential components (6). Many different peptides, including
the 15-residue designed peptide called AH (amphipathic he-
lix), function as activating regions when tethered to DNA
(7–9). In all cases reported thus far, however, natural DNA
binding and dimerization domains have been used to tether
activating regions (natural or designed) to DNA (7–12). It has,
therefore, been difficult to exclude the possibility that these
natural components play some essential role in gene activation
other than to bring the activating region to specific sites
on DNA.
We sought to develop a general motif for artificial tran-
scription factors that would incorporate synthetic counterparts
of all functional modules of naturally occurring activator
proteins and would furthermore be more versatile in their
ability to up-regulate designated genes. In the design of
our synthetic activator, the protein-DNA binding module
was replaced with a hairpin polyamide composed of
N-methylpyrrole (Py) and N-methylimidazole (Im) amino ac-
ids that binds in the minor groove of DNA (Fig. 1A). Hairpin
polyamides are capable of targeting predetermined DNA
sequences with affinities and specificities comparable to DNA
binding proteins in accordance with a simple set of pairing
rules dictated by the side-by-side binding of the aromatic
amino acids (13–15). These synthetic DNA binding ligands are
cell permeable, and one such compound was shown to specif-
ically interfere with gene expression in mammalian cell culture
(16, 17). The hairpin polyamide selected for the present study,
ImPyPyPy-g-PyPyPyPy-b-Dp (where g is g-aminobutyric acid,
b is b-alanine, and Dp is dimethylaminopropylamide), binds
the sequence 59-TGTTAT-39 with a dissociation constant (KD)
of 1.1 nM. In our initial experiments, we targeted a palin-
dromic binding site containing this sequence as an inverted
repeat separated by 7 bp. We used as a dimerization element
a sequence that is known to form a coiled–coil, residues
251–281 of the yeast protein Gcn4 (18). The activation domain
used in all of our experiments was AH (PEFPGIELQEL-
QELQALLQQ) (7).
Methods
Synthesis of Conjugates 3–5. Polyamide 1 was prepared according
to established protocols (19) and then was combined with 1.2
equivalent (eq) thiolane-2,5-dione (20) and 3 eq i-Pr2EtN in
1-methyl-2-pyrrolidinone at a final concentration of 10 mM.
After 15 min, 1.5 vol of 100 mM NaOAc (pH 3.2) were added
followed by 3 eq of benzyl bromide. After an additional 15 min,
the reaction mixture was subjected to purification by reversed-
phase HPLC, and the appropriate fractions were concentrated
to isolate 2 (53%) as a white powder. Matrix-assisted laser
desorptionyionization time of f light (MALDI-TOF) MS anal-
ysis of 2: [M 1 H] calculated (monoisotopic) 1470.7, observed
1470.7. Polyamide 2 (1 mmol) and peptide (0.8–1 mmol) were
combined in 5% 1-methyl-2-pyrrolidinone in 6 M GnzHCl,
100 mM potassium phosphate buffer (pH 7.3), and 10%
(volyvol) thiophenol was added to this solution. Reaction
progress was monitored by analytical HPLC and upon com-
pletion (3–5 d), purification of the mixture by reversed-phase
HPLC resulted in isolation of the desired hairpin polyamide-
peptide conjugates. Yields and characterization: 3 (PA-Gcn4-
AH): 11%, MALDI-TOF [M 1 H] (average mass) calculated
7465.4, observed 7465.4; 4 (PA-Gcn4): 21%, MALDI-TOF:
[M 1 H] (average mass) calculated 5159.8, observed 5159.9; 5
(PA-AH): 22%, MALDI-TOF: [M 1 H] (average mass)
calculated 3774.2, observed 3774.5.
Synthesis of Conjugates 8 –9. The ethylene glycol-derived linker
was prepared as the N-t-butoxycarbonyl amino acid for use in
solid-phase synthesis from 4,7,10-trioxa-1,13-tridecanedia-
mine by monoprotection with N-t-butoxycarbonyl anhydride
followed by reaction with diglycolic anhydride and incorpo-
rated into polyamides 6 and 7 according to established pro-
tocols (19). Transformation into conjugates 8 (PA-1L-AH)and
9 (PA-2L-AH) was accomplished as outlined above. Yields and
characterization: 8: 12%, MALDI-TOF MS [M 1 H] (average
mass) calculated 4164.7, observed 4164.6; 9: 11%, MALDI-
TOF MS [M 1 H] (average mass) calculated 4482.0, observed
4482.2.
Abbreviations: Py, pyrrole; AH, amphipathic helix; MALDI-TOF, matrix-assisted laser de-
sorptionyionization time of flight.
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DNase I Footprinting Titrations. Quantitative DNase I footprinting
titrations were carried out in accordance with established pro-
tocols on a 39-32P-labeled 271-bp pPT7 EcoRIyPvuII restriction
fragment (15, 21). The plasmid pPT7 was kindly provided by S.
Swalley (California Institute of Technology).
In Vitro Transcription Assays. The template plasmid was con-
structed by cloning a 78-bp oligomer bearing three cognate
palindromic sequences into a Bgl2 site 30 bp upstream of the
TATA box of pMLD53. This plasmid has the AdML TATA box
30 bp upstream of a 277-bp G-less cassette. The ‘‘mismatch’’
template was constructed by cloning a 78-bp oligomer con-
taining three palindromic ‘‘mismatch’’ sites into a Bgl2 site 30
bp upstream of the TATA box of pMLD53 (22). For each
reaction, 20 ng of plasmid (30 fmol of palindromic sites) was
preincubated with conjugate for 75 min before the addition of
90 ng of yeast nuclear extract in a 25-ml reaction volume under
standard conditions (23, 24). The reactions were processed as
described (23, 24) and resolved on 8% 30:1 polyacrylamide gels
containing 8 M urea. Gels were dried and exposed to photo-
stimulatable phosphorimaging plates (Fuji). Data were visu-
alized by using a Fuji PhosphorImager followed by quantita-
tion using MACBAS software (Fuji).
Results and Discussion
Synthesis of Artificial Activators. The hairpin polyamides and
peptides were synthesized by solid-phase protocols, and the
peptides each contained an N-terminal cysteine for subsequent
attachment to the polyamide (19). Polyamide 1 then was
treated with thiolane-2,5-dione (20) followed by benzyl bro-
mide to produce thioester 2 functionalized for use in the native
ligation procedure described by Kent and colleagues (Fig. 1B)
(25). Three polyamide-peptide conjugates were prepared by
this sequence. Conjugate 3 (PA-Gcn4-AH) contains the eight-
ring hairpin polyamide as the DNA binding module in addition
to residues 251–281 of the yeast protein Gcn4 as a dimerization
element and the designed peptide AH as the activating region.
The two control compounds 4 (PA-Gcn4) and 5 (PA-AH) each
lack one or another of the three key functional components.
Model building based on available crystal structures (18, 25)
suggested that the polyamide-peptide conjugates would target
the palindromic binding site shown in Fig. 1 A. The data from a
quantitative DNase I footprinting titration between conjugate 3
and DNA containing the 19-bp site were fit by a cooperative
binding isotherm (KD 5 11 nM) (Fig. 2A) (21, 27). The decrease
in overall binding affinity of conjugate 3 relative to the parent
hairpin polyamide is attributed to the attachment of the peptide
at the C-terminal position of the polyamide, known to have a
deleterious effect.
Activation of Transcription. Conjugate 3 (PA-Gcn4-AH) activated
transcription in yeast nuclear extracts on a DNA template
containing three palindromic binding sites upstream of the
start site (Fig. 2B) (23, 24). Thus, inclusion of 3 at 200 nM
concentration in the reactions resulted in 13-fold levels of
activated transcription over basal levels. In control experi-
ments, polyamide alone (1) or polyamide coupled to the Gcn4
dimerization domain (4) but lacking AH did not stimulate
transcription. Furthermore, activation depended on the
presence of cognate polyamide binding sites upstream of
the transcription initiation site. Thus, on a template with
palindromic sites containing a single base pair mismatch
at each half site, conjugate 3 failed to activate significantly
(Fig. 2C).
Time Dependence of Activation. The time course experiment of
Fig. 3A reveals that the activation profile of conjugate 3
(PA-Gcn4-AH) was consistent with that previously deter-
mined for protein transcriptional activators (28). At 20 min,
the level of transcription was 40-fold above the basal level. Fig.
3B shows that at high concentrations of free AH peptide the
activation elicited by conjugate 3 was decreased by 50%. AH
peptide thus competes with the DNA-bound conjugate 3 for
binding to the transcriptional machinery in a phenomenon
Fig. 1. Design and synthesis of activators. (A) The synthetic activator con-
sisting of an activation domain (AD), a dimerization or linker domain (LD), and
a DNA binding domain (DBD) complexed with the cognate palindromic DNA
site of the hairpin polyamide-peptide conjugate. (B) The synthesis of poly-
amide 1 was accomplished according to established protocols. (a) Treatment
of 1 with thiolane-2,5-dione followed by benzyl bromide provided thioester
2 in good yield (53%). (b) Combination of thioester 2 with each peptide in
denaturing buffer then provided the targeted conjugates via the native
ligation reaction.








Fig. 2. Conjugate 3 (PA-Gcn4-AH) binds to its cognate palindromic DNA site and activates transcription in vitro when its predetermined DNA binding sites are
present. (A) (Upper) Storage phosphor autoradiogram of a quantitative DNase I footprinting titration of 3 on the 39-32P-labeled 271-bp pPT7 EcoRIyPvuII
restriction fragment carried out according to established protocols (15, 21). Preequilibration of 3 with the DNA fragment was carried out for 75 min before
initiation of the cleavage reactions. From left to right the lanes are: the A sequencing lane; DNase I digestion products in the presence of 3 at concentrations
of 100 nM, 50 nM, 25 nM, 10 nM, 5 nM, 2.5 nM, 1 nM, 0.5 nM, and 0.25 nM, respectively; DNase I digestion products with no 3 present; undigested DNA. (Lower)
Data for 3 in complex with the 19-bp palindromic site. The curve through the data points is the best-fit cooperative Langmuir binding titration isotherm (n 5
2) obtained from a nonlinear least-squares algorithm. (B) An in vitro transcription reaction containing PA-Gcn4-AH (3) at 200 nM shows enhanced expression
of a 277-nt transcript relative to basal levels whereas a reaction containing conjugate 4, lacking the activating region, does not. Inclusion of the parent hairpin
polyamide (1) (lane 2) in the reaction does not impair basal transcription (lane 1). The variation in transcript position for lane 4 is caused by curvature of the gel
and was confirmed by additional experiments (data not shown). (C) In vitro transcription reactions containing 3 (PA-Gcn4-AH) with templates bearing either the
cognate palindromic binding sites (match template) or palindromic sites in which a GzC base pair has replaced a TzA base pair in each half site (mismatch template)
upstream of the core promoter. The concentrations of 3 used were 0 (basal), 10 nM, 100 nM, and 500 nM.
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referred to as squelching (29, 30). This reinforces the idea that
DNA-tethered AH recruits the transcriptional machinery to
the nearby promoter.
Functional Role of Dimerization Element. The functional necessity of
the dimerization element was investigated by the evaluation of
conjugates containing the activator peptide AH separated by
flexible straight-chain linkers of 12 atoms (conjugate 5), 36
atoms (conjugate 8), and 55 atoms (conjugate 9) (Fig. 4A). As
shown in Fig. 4B, conjugate 8 (PA-1L-AH) activated transcrip-
tion at approximately 50% the level of conjugate 3 (PA-Gcn4-
AH). Increasing the linker length to 55 atoms (conjugate 9) did
not result in a further increase in activation levels; this is likely
because of the flexibility of the linker moiety, which may not
project AH fully away from DNA. The use of a shorter linker (5,
PA-AH) provided a conjugate that activated transcription 25%
as well as did conjugate 3 (PA-Gcn4-AH), suggesting that spatial
separation of the activator module from DNA plays a role in the
efficiency of activation. Two observations demonstrate that
conjugates 5, 8, and 9 do not dimerize. As shown in Fig. 4C, data
from quantitative DNase I footprinting titrations were fit by
noncooperative isotherms (KD for 5 5 19 nM; KD for 8 5 32 nM).
Furthermore, in contrast to titrations containing conjugate 3
(PA-Gcn4-AH), DNase I-mediated cleavage was observed at
positions between the monomeric binding sites within the
palindrome.
Our data demonstrate that each component of a naturally
occurring transcription factor can be substituted with a smaller
non-natural module to provide an artificial transcription factor
with a size of 4.2 kDa. As assayed in our in vitro system,
dimerization per se is not required for activator function, nor
does a natural DNA binding domain play a role in activation
that cannot be substituted by a hairpin polyamide tethering the
activation module to DNA. Finally, because hairpin poly-
amides composed of Py, imidazole, and hydroxypyrrole amino
acid units can in principle be prepared to target a wide range
of predetermined DNA sequences, the class of artificial tran-
scription factors presented here represent a key step toward
up-regulation of physiologically relevant genes by small
molecules.
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Fig. 3. Dependence of activation level upon time and activating region. (A) (Upper) Storage phosphor autoradiogram showing an in vitro transcription
time course experiment with conjugates 3 and 4 present at 300 nM concentration. Aliquots were processed at 10, 20, 30, 40, and 60 min. (Lower) Comparison
of the amount of transcript obtained at each time point relative to basal transcription levels in which no conjugate was present (fold activation). (B) (Upper)
Storage phosphor autoradiogram showing the effect of increasing concentrations of untethered 21-aa AH peptide on transcription reactions containing
either conjugates 4 or 3 at 300 nM concentration. Transcription reactions were performed for 30 min in the presence of 0, 0.2 mM, 2 mM, and 10 mM
concentrations of AH peptide. (Lower) For each reaction, the amount of transcript obtained was compared with basal transcription levels to give the
respective fold activation value. These values are displayed as percent activation compared with the results from the reaction containing conjugate 3 (lane
5), which is defined as 100%.








Fig. 4. Substitution of the dimerization module with a flexible ethylene glycol-derived linker. (A) The synthesis of hairpin polyamides 6 and 7 and conjugates
8 and 9 was carried out as described in Fig. 1B. (B) (Left) Storage phosphor autoradiogram showing in vitro transcription reactions containing parent hairpin
polyamides 1 (lane 2), 6 (lane 4), and 7 (lane 6) or conjugates 5 (lane 3), 8 (lane 5), and 9 (lane 7), which have the AH peptide attached by flexible linkers of
increasing length at 500 nM concentration. A higher conjugate concentration relative to the experiments presented in Figs. 2 and 3 was used to accommodate
the slightly lower binding affinity (2- to 3-fold) of conjugates 5, 8, and 9 relative to conjugate 3 (PA-Gcn4-AH). (Right) The activation levels for conjugates 3, 5,
8, and 9 were determined by comparison with the amount of transcript obtained from reactions containing the relevant parent hairpin polyamides. The fold
activation values thus obtained are displayed as percentages relative to the fold activation mediated by conjugate 3, defined as 100%. (C) Data from DNase I
footprinting titrations with 5 and 8. The curve through each data set is the best-fit Langmuir binding titration isotherm (n 5 1) obtained from a nonlinear
least-squares algorithm.
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